SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS
سعر SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS
98.00 جنية
الشركة المنتجة لـ SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS
MERCK SHARP & DOHME > GLOBAL NAPI PHARMACEUTICALS
المادة الفعالة SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS
MONTELUKAST
معلومات عن SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS
About Montelukast
Leukotriene(CysLT1) Receptor Antagonist Antiinflammatory antiasthma.
Mechanism of Action of Montelukast
Montelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity.
Indications for Montelukast
Asthma.
Interactions for Montelukast
Barbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.